M. L. Blanc

Investigational Drug Steering Committee Trial Design Task Force of the National Cancer Institute Therapeutics : Consensus Recommendations from the Clinical The Design of Phase II Clinical Trials Testing Cancer

D. Berry, J. Crowley, S. Groshen, 2010 .

Algal plating as a tool for investigating allelopathy among marine microalgae

Paul J. Harrison, Raymond J. Andersen, R. Andersen, 1980 .

1-(2,6,6-Trimethyl-4-hydroxycyclohexenyl)-1,3-butanedione, an extracellular metabolite from the dinoflagellate Prorocentrum minimum

R. Andersen, F. Sum, M. L. Blanc, 1980 .